Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.

id	oai:revistas.unicordoba.edu.co:article_528
record_format	ojs
spelling	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos. Matta, Salim Arango, Álvaro I. Visbal, Jorge 6 2 Núm. 2 , Año 2001 : Revista MVZ Córdoba volumen 6(2) Julio-Diciembre 2001 Artículo de revista Journal article 2001-07-01T00:00:00Z 2001-07-01T00:00:00Z 2001-07-01 application/pdf Universidad de Córdoba Revista MVZ Córdoba 0122-0268 1909-0544 https://revistamvz.unicordoba.edu.co/article/view/528 10.21897/rmvz.528 https://doi.org/10.21897/rmvz.528 https://creativecommons.org/licenses/by-nc-sa/4.0/ Arango A I. Chlamydia y Rickettsia. En Máttar S, & Melo A, Editores. Bacteriología clínica: estudio etiológico de las enfermedades infecciosas de origen bacteriano. 1998; Editorial CEJA. Bogotá. Baehr W, Zhang, Y, Joseph T, Su H, Nano FE, Everett DE, et al: Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci USA 1988; 85:4000-4004. http://dx.doi.org/10.1073/pnas.85.11.4000 Bavoil P: Invation and Intracellular Growth of Chlamydia Species. En: Iglewski BH, Clark VI (Eds): Molecular Basis of Bacterial Pathogenesis. Academic Press. 1990. Bergeys Manual of Determinative Bacteriology, Ninth Edition, Willians & Wilkins Baltimore, USA 1994; 351. Black C. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-184. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994; 3:218-33. Centers for Disease Control, Division of Sexually Transmitted Diseses: STD treatment guidelines. MMWR 1995; 34(4S). Dahlen G, J. Boman, L. S. Birgander, and P. Lindblom. LP (A) lipropotein, IgG, IgA, IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995; 114 :165-174. http://dx.doi.org/10.1016/0021-9150(94)05480-7 Fong I, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997; 35:48-52. Kapusnik-Uner JE, Sande MA, Chambers HF. Tetracyclines, Choramphenicol, Erytromycin, and Miscellaneous Antibacterial Agents in Goodman & Gilman's The pharmacological Basis of Therapeutics. Ninth Edition. The Mc Graw-Hill Companies. 1996; 1123-1153. Kuo CC, Shor A, Campbell L, Fukushi H, Patton D, Grayston JT. Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries. J Infect Dis 1993; 167:841-9. http://dx.doi.org/10.1093/infdis/167.4.841 Magid D, Douglas JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996; 124:389-99. http://dx.doi.org/10.7326/0003-4819-124-4-199602150-00002 McClarty G. Chlamydiae and the biochemistry of intracellular parasitism. Trends Microbiol 1994; 2:157-64. http://dx.doi.org/10.1016/0966-842X(94)90665-3 Melnick S. L, E. Shahar A. R. Fulsom J. T. Grayston P. D. Sorlie F. P. Wang. and M. Szkzo. Past infection by Chlamydia pneumoniae strain: TWAR and asymptomatic carotid atherosclerosis: atherosclerosis risk in communities (ARIC): study investigators. Am J Med 1993; 95:499-504. http://dx.doi.org/10.1016/0002-9343(93)90332-J Mendall M. A, D. Carrington D. Strachan, P. Patel, N. Molineaux J. Levi, T. Toosey A. K. Camm, and T. C. Northfield. Chlamydia pneumoniae: risk factor for seropositivy and association with coronary artery disease. J Infect 1995; 30:121-128. http://dx.doi.org/10.1016/S0163-4453(95)80006-9 Mlot Ch. Probing Chamydia connection to atheroesclerosis. Asm- News 1996; 62:521. Morré SA, Sillekens P, Jacobs MV, Van Aarle P, Blok S, Van Gemen B, Jan M, Walboomers M, Chris J, Meijer LM, And Adriaan J, Van den Brule C. RNA Amplification by Nucleic Acid SequenceBased Amplification with an Internal Standard Enables Reliable Detection of Chlamydia trachomatis in Cervical Scrapings and Urine Samples. J Clin Microbiol. 1996; 34:3108-3114. Morrison RP, Belland RJ, Lyng D, Caldwell HD: Chlamydial disease pathogenesis. The 57 kDa chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 25:170:1271 Ossewaarde JM, Plantema FHF, Rieffe M, Nawrocki RP, de Vries A, Van Loon AM. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis 1992; 11:693-7. http://dx.doi.org/10.1007/BF01989972 Patel P, M. A. Mendall D. Carrington D. P. Strauchan E. Leatham, N. Molienaux, J. Levi, C. Blakeston, C. A. Seymour, A. K. Camm et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factor. Br Med J 1995; 311:711-714. http://dx.doi.org/10.1136/bmj.311.7007.711 Peeling RW. Chlamydia trachomatis and Neisseria gonorrhoeae: Pathogens in retreat? Current Opinion in Infections Diseases 1995; 8:26-34. http://dx.doi.org/10.1097/00001432-199502000-00006 Reese R, Bets R.Sulfonamides and TrimethropimSulfamethoxazole in Handbook of Antibiotics. Second Edition. Little, Brown and Company. Boston & New York. USA. 1993; 271-427. Schachter J, Grossman M, Azimi PH: Serology of Chlamydia trachomatis in infants. J Infect Dis 1982; 146: 53. http://dx.doi.org/10.1093/infdis/146.4.530 Verkooyen RP, Luijendijk A, Huisman WM, Goessens WHF, Kluytmans JAJW, Van RijsoortVos JH, Verbrugh HA. Detection of PCR Inhibitors in Cervical Specimens by Using the Amplicor Chlamydia trachomatis Assay. J Clin Microbiol. 1996; 34:3072-3074. Woods ML, Robinson EN Jr., McGee ZA, Hitchcok PJ. Chlamydiae-Genital and Respiratory Pathogens in Mechanisms of Microbial Disease. Shaechter M, Medoff G, Eisenstein B I. Second Edition. Williams & Wilkins. Baltimore, Maryland. USA. 1989; 350-357. https://revistamvz.unicordoba.edu.co/article/download/528/596 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication
institution	UNIVERSIDAD DE CORDOBA
thumbnail	https://nuevo.metarevistas.org/UNIVERSIDADDECORDOBA/logo.png
country_str	Colombia
collection	Revista MVZ Córdoba
title	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
spellingShingle	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos. Matta, Salim Arango, Álvaro I. Visbal, Jorge
title_short	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_full	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_fullStr	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_full_unstemmed	Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
title_sort	chlamydia trachomatis: aspectos microbiológicos, clínicos y epidemiológicos.
author	Matta, Salim Arango, Álvaro I. Visbal, Jorge
author_facet	Matta, Salim Arango, Álvaro I. Visbal, Jorge
citationvolume	6
citationissue	2
citationedition	Núm. 2 , Año 2001 : Revista MVZ Córdoba volumen 6(2) Julio-Diciembre 2001
publisher	Universidad de Córdoba
ispartofjournal	Revista MVZ Córdoba
source	https://revistamvz.unicordoba.edu.co/article/view/528
language
format	Article
rights	https://creativecommons.org/licenses/by-nc-sa/4.0/ info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_6501
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2001-07-01
date_accessioned	2001-07-01T00:00:00Z
date_available	2001-07-01T00:00:00Z
url	https://revistamvz.unicordoba.edu.co/article/view/528
url_doi	https://doi.org/10.21897/rmvz.528
issn	0122-0268
eissn	1909-0544
doi	10.21897/rmvz.528
url2_str_mv	https://revistamvz.unicordoba.edu.co/article/download/528/596
_version_	1811201103428059136

Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos. .

Código QR

Estadísticas y Métricas Alternativas

Títulos similares

Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
.